Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Derma Pella Pharmaceuticals, also known as Pella Pharmaceuticals, is a specialized pharmaceutical company based in Jordan that focuses on the research, development, and manufacturing of dermatological and cosmeceutical products. Established in 2005, the company offers a comprehensive portfolio of therapeutic solutions for skin conditions such as acne, psoriasis, eczema, and hair loss, alongside aesthetic products for skin whitening and sun protection. Derma Pella operates a state-of-the-art manufacturing facility in the Al-Hassan Industrial Estate, which adheres to international Good Manufacturing Practice (GMP) standards. The company serves a broad geographic market, exporting its high-quality topical formulations to numerous countries across the Middle East, Africa, and Europe. Their commitment to innovation in topical drug delivery has established them as a prominent leader in the regional dermatology sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Derma Pella.